Gregory S. Calip
University of Southern California
ORCID: 0000-0002-7744-3518Also affiliated with AbbVie (United States)
Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Indexed papers
Papers
Driven by 12 papers. Top paper: “Targets of biologic disease‐modifying antirheumatic drugs and risk of multiple myeloma”.
Pritesh Patel, Karen Sweiss, Zhaoju Wu, Jifang Zhou, Alemseged Ayele Asfaw +4 more
Ashwini Zolekar, Naomi Y. Ko, Gregory S. Calip, Nita H. Mukand
Gregory S. Calip, Edith A. Nutescu, Jin Han, Surrey M. Walton, Andrew Srisuwananukorn +2 more
Karen Sweiss, Jin Han, Naomi Y. Ko, Pritesh Patel, Brian C.‐H. Chiu +2 more
Mary H. Smart, Ashwini Zolekar, Huiwen Deng, Colin C. Hubbard, Kent Hoskins +4 more
Swetha Ramanathan, Katie J. Suda, Tumader Khouja, Susan Rowan, Charlesnika T. Evans +5 more
Xiaoliang Wang, Harlan Pittell, Gregory S. Calip, Stephanie E. Weiss, Joshua E. Meyer +2 more
Caryn E. Peterson, Shannon MacLaughlan David, Abdullah Abdelaziz, George F. Sawaya, Jenny S. Guadamuz +2 more
Ronac Mamtani, Yun Li, Sandra D. Griffith, Gregory S. Calip, Rebecca A. Hubbard +1 more
Krystal Lau, Xiaoliang Wang, Amy J. Davidoff, Scott F. Huntington, Omer Jamy +9 more
Colin Cernik, Hajime Uno, Thomas Walsh, Gregory S. Calip, Daniel J. DeAngelo +3 more
Mustafa Ascha, Kristin Waite, Mantas Dmukauskas, Xiaoliang Wang, Trevor J. Royce +6 more